Curcumin blocks small cell lung cancer cells migration, invasion, angiogenesis, cell cycle and neoplasia through janus kinase-STAT3 signalling pathway

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Yang, Cheng Liang ^a   Liu, Yong Yu ^a   Ma, Ye Gang ^a   Xue, Yi Xue ^b   Liu, De Gui ^a   Ren, Yi ^a   Liu, Xiao Bai ^b   Li, Yao ^b   Li, Zhen ^b  

^a LIAONING CANCER HOSPITAL AND INSTITUTE   (China)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; CYCLIN B1; GELATINASE A; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; JANUS KINASE; MATRILYSIN; PROTEIN BCL XL; SMALL INTERFERING RNA; STAT3 PROTEIN; SURVIVIN; VASCULOTROPIN;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER INVASION; CANCER PREVENTION; CARCINOGENESIS; CELL CYCLE; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG INHIBITION; DRUG POTENCY; GENE SILENCING; HUMAN; HUMAN CELL; LUNG SMALL CELL CANCER; MALIGNANT NEOPLASTIC DISEASE; PHARMACOLOGICAL BLOCKING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEINASE INHIBITION; SIGNAL TRANSDUCTION; TUMOR GROWTH;

ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CURCUMIN; CYCLIN B1; HUMANS; INTERLEUKIN-6; JANUS KINASES; LUNG NEOPLASMS; MATRIX METALLOPROTEINASES; NEOVASCULARIZATION, PATHOLOGIC; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SMALL CELL LUNG CARCINOMA; STAT3 TRANSCRIPTION FACTOR;

CURCUMA LONGA;

EID: 84861476075     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037960     Document Type: Article

References (34)

1. Hedvat M, Huszar D, Herrmann A, Gozgit JM, Schroeder A, et al. (2009) The JAK2 inhibitor AZD1480 potently blocks STAT3 signaling and oncogenesis in solid tumors. Cancer Cell 16: 487-497.
2. Huang S, (2007) Regulation of metastases by signal transducer and activator of transcription 3 signaling pathway: clinical implications. Clin Cancer Res 13: 1362-1366.
3. Koppikar P, Lui VW, Man D, Xi S, Chai RL, et al. (2008) Constitutive activation of signal transducer and activator of transcription 5contributes to tumor growth, epithelial-mesenchymal transition, and resistance to epidermal growth factor receptor targeting. Clin Cancer Res 14: 7682-7690.
4. Gao SP, Mark KG, Leslie K, Pao W, Motoi N, et al. (2007) Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas. J Clin Invest 117: 3846-3856.
5. Haura EB, Zheng Z, Song L, Cantor A, Bepler G, (2005) Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in nonsmall cell lung cancer. Clin Cancer Res 11: 8288-8294.
6. Sánchez-Ceja SG, Reyes-Maldonado E, Vázquez-Manríquez ME, López-Luna JJ, Belmont A, et al. (2006) Differential expression of STAT5 and Bcl-xL, and high expression of Neu and STAT3 in non-small-cell lung carcinoma. Lung Cancer 54: 163-168.
7. Johnson FM, Saigal B, Talpaz M, Donato NJ, (2005) Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells. Clin Cancer Res 11: 6924-6932.
8. Song L, Turkson J, Karras JG, Jove R, Haura EB, (2003) Activation of STAT3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells. Oncogene 22: 4150-4165.
9. Pfeiffer M, Hartmann TN, Leick M, Catusse J, Schmitt-Graeff A, et al. (2009) Alternative implication of CXCR4 in JAK2/STAT3 activation in small cell lung cancer. Br J Cancer 100: 1949-1956.
10. Hoffman PC, Mauer AM, Vokes EE, (2000) Lung cancer. Lancet 355: 479-485.
11. Jemal A, Siegel R, Xu J, Ward E, (2010) Cancer statistics.2010. CA Cancer J Clin 60: 77-300.
12. Magadula JJ, Erasto P, (2009) Bioactive natural products derived from the East African flora. Nat Prod Rep 12: 1535-1554.
13. Manju V, Nalini N, (2005) Chemopreventive efficacy of ginger, a naturally occurring anticarcinogen during the initiation, post-initiation stages of 1,2 dimethylhydrazine-induced colon cancer. Clin Chim Acta 358: 60-67.
14. Dorai T, Aggarwal BB, (2004) Role of chemopreventive agents in cancer therapy. Cancer Lett 215: 129-140.
15. Sinha R, Anderson DE, McDonald SS, Greenwald P, (2003) Cancer risk and diet in India. J Postgrad Med 49: 222-228.
16. Yang CL, Ma YG, Xue YX, Liu YY, Xie H, et al. (2012) Curcumin induces small cell lung cancer NCI-H446 cell apoptosis via the reactive oxygen species-mediated mitochondrial pathway and not the cell death receptor pathway. DNA Cell Biol 31: 139-150.
17. Ara T, Song L, Shimada H, Keshelava N, Russell HV, et al. (2009) Interleukin-6 in the bone marrow microenvironment promotes the growth and survival of neuroblastoma cells. Cancer Res 69: 329-337.
18. Klausen P, Pedersen L, Jurlander J, Baumann H, (2000) Oncostatin M and interleukin 6 inhibit cell cycle progression by prevention of p27kip1 degradation in HepG2 cells.Oncogene 19: 3675-3683.
19. Missale C, Codignola A, Sigala S, Finardi A, Paez-Pereda M, et al. (1998) Nerve growth factor abrogates the tumorigenicity of human small cell lung cancer cell lines. Proc Natl Acad Sci USA 95: 5366-5371.
20. Darnell JE Jr, (1997) STATs and gene regulation. Science 277: 1630-1635.
21. Frank DA, (2007) STAT3 as a central mediator of neoplastic cellular transformation. Cancer Lett] 251: 199-210.
22. Mukhopadhyay A, Banerjee S, Stafford LJ, Xia C, Liu M, et al. (2002) Curcumin-induced suppression of cell proliferation correlates with downregulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation. Oncogene 21: 8852-8861.
23. Weinstein IB, (2000) Disorders in cell circuitry during multistage carcinogenesis: the role of homeostasis. Carcinogenesis 21: 857-864.
24. Gasparini G, Longo R, Sarmiento R, Morabito A, (2003) Inhibitors of cyclooxygenase 2:a new class of anticancer agents? Lancet Oncol.4: 605-615.
25. Shiraga M, Yano S, Yamamoto A, Ogawa H, Goto H, et al. (2002) Organ heterogeneity of host-derived matrix metalloproteinase expression and its involvement in multiple-organ metastasis by lung cancer cell lines. Cancer Res 62: 5967-5973.
26. Garg A, Aggarwal BB, (2002) Nuclear transcription factor-kappaB as a target for cancer drug development. Leukemia 16: 1053-1068.
27. Saydmohammed M, Joseph D, Syed V, (2010) Curcumin suppresses constitutive activation of STAT-3 by up-regulating protein inhibitor of activated STAT-3 (PIAS-3) in ovarian and endometrial cancer cells. J Cell Biochem 110: 447-456.
28. Kim DK, Oh SY, Kwon HC, Lee S, Kwon KA, et al. (2009) Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancer. BMC Cancer 9: 155.
29. Leeman-Neill RJ, Wheeler SE, Singh SV, Thomas SM, Seethala RR, et al. (2009) Guggulsterone enhances head and neck cancer therapies via inhibition of signal transducer and activator of transcription-3. Carcinogenesis 30: 1848-1856.
30. Yang C, Schwab JH, Schoenfeld AJ, Hornicek FJ, Wood KB, et al. (2009) A novel target for treatment of chordoma: signal transducers and activators of transcription 3. Mol. Cancer Ther 8: 2597-2605.
31. Lo HW, Cao X, Zhu H, Ali-Osman F, (2008) Constitutively activated STAT3 frequently coexpresses with epidermal growth factor receptor in high-grade gliomas and targeting STAT3 sensitizes them to Iressa and alkylators. Clin Cancer Res. 14: 6042-6054.
32. Fletcher S, Turkson J, Gunning PT, (2008) Gunning, Molecular approaches towards the inhibition of the signal transducer and activator of transcription 3 (Stat3) protein. Chem Med Chem 3: 1159-1168.
33. McLaughlin J, Cheng D, Singer O, Lukacs RU, Radu CG, et al. (2007) Sustained suppression of Bcr-Abl-driven lymphoid leukemia by microRNA mimics. Proc Natl Acad Sci U S A. 104: 20501-20506.
34. Chen HW, Yu SL, Chen JJ, Li HN, Lin YC, et al. (2004) Anti-invasive gene expression profile of curcumin in lung adenocarcinoma based on a high throughput microarray analysis. Mol Pharmacol 65: 99-110.